Literature DB >> 16887106

Fmrp is required for the establishment of the startle response during the critical period of auditory development.

Seong-Wook Yun1, Jimcy Platholi, Maria Sol Flaherty, Weimin Fu, Andreas H Kottmann, Miklos Toth.   

Abstract

Fragile X syndrome, the most common form of inherited mental retardation, is caused by the absence of the FMR-1 gene product FMRP. In addition to the hallmark cognitive defect, other symptoms are also apparent including hyperactivity, seizures and sensory abnormalities including a characteristic increase in sensitivity to auditory, tactile, visual, and olfactory stimuli. Fragile X is a developmental disorder with the first symptoms apparent in the first year of life but little is known about the role of FMRP in developmental processes. The sensory hyperreactivity of fragile X can be reproduced in fmr-1 knockout (KO) mice evident as abnormal audiogenic startle response and increased audiogenic seizure susceptibility. Here, we studied the onset and emergence of the startle deficit in fmr-1 KO mice during development. The startle response was first detectable at the end of the 2nd postnatal week in wild-type mice. The amplitude of startle response showed a substantial increase until the 4th postnatal week followed by a further but moderate increase up to adulthood. Expression of the fmr1 gene was detectable in the startle circuit before the onset and throughout the development of the startle response. Although the onset and amplitude of the startle response were not altered in fmr1 KO mice until the 3rd-4th postnatal week, beyond this age it failed to develop further resulting in an overall response deficit in adult KO mice. This indicates that although Fmrp is dispensable at the initial steps of startle response development, it is necessary for the full development of the response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887106     DOI: 10.1016/j.brainres.2006.06.086

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  26 in total

1.  The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.

Authors:  Jose Luis Olmos-Serrano; Joshua G Corbin; Mark P Burns
Journal:  Dev Neurosci       Date:  2011-11-08       Impact factor: 2.984

Review 2.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

Review 3.  Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.

Authors:  D Sinclair; B Oranje; K A Razak; S J Siegel; S Schmid
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

4.  Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.

Authors:  Jamiela Kokash; Erin M Alderson; Sarah M Reinhard; Cynthia A Crawford; Devin K Binder; Iryna M Ethell; Khaleel A Razak
Journal:  Brain Res       Date:  2019-05-22       Impact factor: 3.252

5.  Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome.

Authors:  Feng Pan; Georgina M Aldridge; William T Greenough; Wen-Biao Gan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-22       Impact factor: 11.205

Review 6.  Acoustic startle modification as a tool for evaluating auditory function of the mouse: Progress, pitfalls, and potential.

Authors:  Amanda M Lauer; Derik Behrens; Georg Klump
Journal:  Neurosci Biobehav Rev       Date:  2017-03-19       Impact factor: 8.989

7.  Inactivation of the maternal fragile X gene results in sensitization of GABAB receptor function in the offspring.

Authors:  Bojana Zupan; Miklos Toth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-23       Impact factor: 4.030

8.  Wild-type male offspring of fmr-1+/- mothers exhibit characteristics of the fragile X phenotype.

Authors:  Bojana Zupan; Miklos Toth
Journal:  Neuropsychopharmacology       Date:  2008-01-02       Impact factor: 7.853

Review 9.  From FMRP function to potential therapies for fragile X syndrome.

Authors:  Ferzin Sethna; Changjong Moon; Hongbing Wang
Journal:  Neurochem Res       Date:  2013-12-18       Impact factor: 3.996

10.  Temporal requirements of the fragile x mental retardation protein in modulating circadian clock circuit synaptic architecture.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Neural Circuits       Date:  2009-08-20       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.